The drug,not the company.In my opinion focus on the drug and the concept,that will ultimately be recognized and catch on.That is why I think the company will partner or sell.Remember the gem is the drug,concept and intellectual property.
Although mgmt is inept, you've summed it up well. The company has great value, albeit, not yet tapped. I agree it will take a big pharma to really get the value from what they have.
Gold screwed it up. Johnson's only job should be to sell this for a reasonable price .. And step aside. Right now 15 looks good, which is sad. If he had gotten a deal done shortly after his hire, I bet we would have gotten 25-30. Let's get it done Johnson. Pretty soon 10 bucks will look sweet.
Not sure what he's waiting for?